ArticleThoracic cancer2022

Multicenter real-world data of patients harboring rare mutations other than EGFR or ALK in advanced or metastatic non-small cell lung cancer.

Su Yeon Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.